Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Bozinovski (Bundoora, Australia). Late Breaking Abstract - Aspirin-triggered resolvin D1 reduces pneumococcal lung burden in a viral and bacterial co-infection pneumonia model. 3925

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Aggravated pathology in MRSA pneumonia secondary to Influenza A virus infection diverged from decreased expression of IL-1ß Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020 Late Breaking Abstract - The pro-inflammatory activity and role of NLRP3 inflammasome in severe influenza A virus pneumonia. Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond Year: 2021 Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations? Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Epidemic and pandemic viral infections: impact on tuberculosis and the lung Source: Eur Respir J, 56 (4) 2001727; 10.1183/13993003.01727-2020 Year: 2020 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 The role of viral infection in the progression of community-acquired pneumonia (CAP) Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008 The role of human neutrophil defensins in patients with pneumonia caused by influenza A (H1N1v) Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 Bacterial infection and COPD - cause or effect? Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018 Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations Source: International Congress 2019 – Airway physiology Year: 2019 The role of viral and bacterial infections on the development and exacerbations of asthma Source: Eur Respir Mon 2012; 56: 115-127 Year: 2012 Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015